Condition

Cholelithiases

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common interventions4

Lead sponsors shown3

Clinical trials

3 shown

A Prospective, Single-center, Single-arm, Pivotal Trial of the Medtronic Hugo™ Robotic Assisted Surgery (RAS) SystemNCT05715827 · 2023-02-12

COMPLETED

Multicenter Cohort of 768 High-risk Patients With Symptomatic Gallstones, Adding Cholecystectomy Did Not Increase Length of Stay or Perioperative Morbidity, Supporting it as a Safe Single-stage OptionNCT07772440 · 2015-01-01

COMPLETED

Genomic Resources for Enhancing Available Therapies (GREAT1.0) StudyNCT04306939 · 2014-11-01

SUSPENDED

Common interventions

Additional Sample CollectionsOTHER1 QuestionnairesBEHAVIORAL1 RAS prostatectomy and RAS cholecystectomyDEVICE1 venipunctureOTHER1

Leading sponsors

Medtronic - MITG 1 University of Pittsburgh 1 Zagazig University 1

Trial status mix

COMPLETED2

SUSPENDED1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.